ML19259A060
| ML19259A060 | |
| Person / Time | |
|---|---|
| Site: | 99902077 |
| Issue date: | 10/17/2019 |
| From: | Linh Tran Research and Test Reactors Licensing Projects Branch |
| To: | Eden Radioisotopes |
| M, Gavello, NRR/PRLB, 415-0565 | |
| Shared Package | |
| ML19255G842 | List: |
| References | |
| EPID L-2019-LLL-0027 | |
| Download: ML19259A060 (4) | |
Text
October 17, 2019 LICENSEE: Eden Radioisotopes, LLC
SUBJECT:
SUMMARY
OF SEPTEMBER 10, 2019, MEETING WITH EDEN RADIOISOTOPES, LLC (EPID NO. L-2019-LLL-0027)
On September 10, 2019, a Category 1 public meeting was held between the U.S. Nuclear Regulatory Commission (NRC) staff and representatives of Eden Radioisotopes, LLC (Eden) at NRC Headquarters, One White Flint North, 11555 Rockville Pike, Rockville, Maryland. The purpose of this meeting was to discuss the ongoing development and design of Edens proposed medical radioisotope production project. The meeting notice and agenda, dated August 20, 2019, are available in the Agencywide Documents Access and Management System (ADAMS) at Accession No. ML19232A451. Edens presentation used in the meeting is also available in ADAMS at Accession No. ML19255G793. A list of meeting attendees is provided as an enclosure to this summary.
Eden presented an overview of its company and proposed molybdenum-99 production technology. Eden identified three areas of primary development: target irradiation, target processing, and target fabrication. Eden described the technology of its proposed 2-megawatt thermal reactor with a design that includes a flexible core configuration, open pool system with natural circulation, and an annular hexagonal array of uranium targets and drivers.
Eden then discussed the general layout for the reactor facility, hot cell facility, and fuel fabrication facility. Eden stated that it plans to process up to 500 grams of low-enriched uranium as a batch in the facility. The NRC staff described licensing requirements in Title 10 of the Code of Federal Regulations (10 CFR) Part 50, Domestic Licensing of Production and Utilization Facilities, and 10 CFR Part 70, Domestic Licensing of Special Nuclear Material.
Eden presented the development of the integrated safety analysis (ISA) for the reactor facility, hot cell facility, and the fuel fabrication facility, including the phases and scope of the ISA. Eden described the maximum hypothetical accidents for the reactor and the hot cell facilities. Eden also described the proximity of its proposed facility in Eunice, New Mexico to other facilities and to the nearest resident. Eden discussed the progress of the environmental report. The NRC staff described the requirements in 10 CFR Part 51, Environmental Protection Regulations for Domestic Licensing and Related Regulatory Functions, for the environmental review.
Eden plans to request additional pre-application meetings to discuss its proposed licensing approach further with the NRC staff.
Please direct any inquiries to Linh Tran at 301-415-4103 or Linh.Tran@nrc.gov Sincerely,
/RA/
Linh N. Tran, Senior Project Manager Non-Power Production and Utilization Facility Licensing Branch Division of Advanced Reactors and Non-Power Production and Utilization Facilities Office of Nuclear Reactor Regulation Project/Docket No. 99902077
Enclosure:
As stated cc: w/enclosure:
Mr. Bennett Lee, CEO/Co-Founder Eden Radioisotopes, LLC 6100 Indian School Road NE Suite 125 Albuquerque, NM 87110
ML19255G842 Pkg ML19232A451 Mtg. Notice ML19259A060, Mtg. Summary ML19255G793 Slides *concurred via email NRC-001 OFFICE NRR/DLP/PRLB/PM NRR/DLP/PRLB/PM NRR/DLP/PRLB/LA NRR/DLP/PRLB/BC NRR/DLP/PRLB/PM NAME MGavello LTran NParker GCasto LTran DATE 10/15/19 10/15/19 10/15/2019 10/16/2019 10/17/2019 LIST OF ATTENDEES SEPTEMBER 10, 2019, MEETING WITH EDEN RADIOISOTOPES, LLC.
1:00 P.M. - 4:10 P.M.
Name Organization Linh Tran U.S. Nuclear Regulatory Commission Molly-Kate Gavello U.S. Nuclear Regulatory Commission Brian Smith U.S. Nuclear Regulatory Commission Greg Casto U.S. Nuclear Regulatory Commission Mary Jane Ross-Lee U.S. Nuclear Regulatory Commission Joseph Staudenmeier U.S. Nuclear Regulatory Commission James Hammelman U.S. Nuclear Regulatory Commission Joseph McManus U.S. Nuclear Regulatory Commission Alexander Adams U.S. Nuclear Regulatory Commission Jacob Zimmerman U.S. Nuclear Regulatory Commission Mitzi Young U.S. Nuclear Regulatory Commission Yawar Faraz U.S. Nuclear Regulatory Commission David Tiktinsky U.S. Nuclear Regulatory Commission Robert Schaaf U.S. Nuclear Regulatory Commission Steven Lynch U.S. Nuclear Regulatory Commission William Rautzen U.S. Nuclear Regulatory Commission Kevin Folk U.S. Nuclear Regulatory Commission Robert Hoffman U.S. Nuclear Regulatory Commission Jeffrey Rikhoff U.S. Nuclear Regulatory Commission Michael Balazik U.S. Nuclear Regulatory Commission Nancy Martinez U.S. Nuclear Regulatory Commission Chris Hoxie U.S. Nuclear Regulatory Commission Charles Teal U.S. Nuclear Regulatory Commission Tarek Zaki U.S. Nuclear Regulatory Commission Phyllis Clark U.S. Nuclear Regulatory Commission Ed Parma Eden Radioisotopes, LLC Paul Helmick Eden Radioisotopes, LLC Bennett Lee Eden Radioisotopes, LLC Dick Coats Eden Radioisotopes, LLC Milton Vernon Eden Radioisotopes, LLC Jessica Bridges Eden Radioisotopes, LLC Anthony Baca Eden Radioisotopes, LLC Carolyn Haass Northwest Medical Isotopes, LLC Enclosure